Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

BACKGROUND: The coronavirus disease (COVID-19) epidemic has not been completely controlled. Although great achievements have been made in COVID-19 research and many antiviral drugs have shown good therapeutic effects against COVID-19, a simple oral antiviral drug for COVID-19 has not yet been develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Wen, Chen, Chen, Tang, Jiake, Wang, Chunyi, Zhou, Mengyun, Cheng, Yongran, Zhou, Xiang, Wu, Qi, Zhang, Xingwei, Feng, Zhanhui, Wang, Mingwei, Mao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820829/
https://www.ncbi.nlm.nih.gov/pubmed/35118917
http://dx.doi.org/10.1080/07853890.2022.2034936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820829/
https://www.ncbi.nlm.nih.gov/pubmed/35118917
http://dx.doi.org/10.1080/07853890.2022.2034936

Ejemplares similares